Mammography News and Research RSS Feed - Mammography News and Research

A mammogram is a safe test used to look for any problems with a woman's breasts. The test uses a special, low-dose x-ray machine to take pictures of both breasts. The results are recorded on x-ray film or directly onto a computer for a radiologist to examine.

Mammograms allow the doctor to have a closer look for breast lumps and changes in breast tissue. They can show small lumps or growths that a doctor or woman may not be able to feel when doing a clinical breast exam. "Mammography" is the best screening tool that doctors have for finding breast cancer.

If a lump is found, your doctor may order other tests, such as ultrasound or a biopsy--a test where a small amount of tissue is taken from the lump and area around the lump. The tissue is sent to a lab to look for cancer or changes that may mean cancer is likely to develop. Breast lumps or growths can be benign (not cancer) or malignant (cancer). Finding breast cancer early means that a woman has a better chance of surviving the disease. There are also more choices for treatment when breast cancer is found early.
Columbia University researchers analyze results of Oregon Health Experiment

Columbia University researchers analyze results of Oregon Health Experiment

Researchers at Columbia University's Mailman School of Public Health analyzed the results of the Oregon Health Experiment, where eligible uninsured individuals were randomly assigned Medicaid or to stay with their current care. Considered controversial because the experiment found no measurable gains for physical health it did reveal benefits for mental health, financial wellbeing, and preventive screening. [More]
Risk-based mammography screening can miss invasive cancers in women in their 40s

Risk-based mammography screening can miss invasive cancers in women in their 40s

A study of breast cancers detected with screening mammography found that strong family history and dense breast tissue were commonly absent in women between the ages of 40 and 49 diagnosed with breast cancer. [More]
Digital tomosynthesis improves cancer detection in women with dense breasts

Digital tomosynthesis improves cancer detection in women with dense breasts

A major new study being presented at the annual meeting of the Radiological Society of North America (RSNA) has found that digital breast tomosynthesis, also known as 3-D mammography, has the potential to significantly increase the cancer detection rate in mammography screening of women with dense breasts. [More]
Bayer unveils enhanced version of Radimetrics Enterprise Platform at RSNA 2014

Bayer unveils enhanced version of Radimetrics Enterprise Platform at RSNA 2014

Bayer today unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America Scientific Assembly and Annual Meeting. The enhanced version has new features that can help radiologists and hospital administrators meet new 2015 U.S. Joint Commission Diagnostic Imaging Standards, providing information to help optimize radiation dose management and contrast dose analytics to advance image quality and patient care. [More]
Gamma Medica, Volpara Solutions partner to improve breast cancer screening

Gamma Medica, Volpara Solutions partner to improve breast cancer screening

Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, is pleased to announce a new strategic partnership with Volpara Solutions, leaders in the development of quantitative breast imaging tools. By using these technologies in parallel, physicians can implement screening protocols based on a woman’s breast density and individual risk factors. [More]
Gamma Medica to offer Philips MicroDose SI as complement to LumaGEM MBI system

Gamma Medica to offer Philips MicroDose SI as complement to LumaGEM MBI system

Gamma Medica today announces the company will now offer Philips MicroDose SI, the first full-field digital mammography (FFDM) system that supports single-shot, non-invasive spectral imaging, as a complement to its market leading LumaGEM Molecular Breast Imaging (MBI) system. [More]
Study shows effectiveness of VolitionRx’s NuQ test in detecting lung cancer in blood and sputum

Study shows effectiveness of VolitionRx’s NuQ test in detecting lung cancer in blood and sputum

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that data from its pilot lung cancer study will be presented at the Science for Business BioWin Day 2014, being held November 26, 2014 in Louvain-la-Neuve, Belgium. [More]

New device may reduce discomfort of breast compression in mammography

Researchers have developed a new device that may result in more comfortable mammography for women. According to a study being presented next week at the annual meeting of the Radiological Society of North America, standardizing the pressure applied in mammography would reduce pain associated with breast compression without sacrificing image quality. [More]
ContextVision to launch new groundbreaking product for 3D ultrasound at RSNA 2014

ContextVision to launch new groundbreaking product for 3D ultrasound at RSNA 2014

At the upcoming 100th Scientific Assembly and Annual Meeting of RSNA, ContextVision, will launch a new groundbreaking product range for 3D ultrasound. The new second generation of 3D volume processing and the photo-like 3D rendering software provides new features that brings 3D imaging to a higher level. The products offer a higher diagnostic value and support further use of 3D ultrasound. [More]
Study highlights potential benefit of follow-up screening for woman with early breast cancer

Study highlights potential benefit of follow-up screening for woman with early breast cancer

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health system perspective. [More]
Higher Medicaid reimbursements for routine office visits linked to more cancer screening tests

Higher Medicaid reimbursements for routine office visits linked to more cancer screening tests

Medicaid reimbursements for office visits to the doctor and for cancer screening tests vary substantially from state to state. New research in the journal Cancer finds that Medicaid recipients are more likely to receive cancer screening tests when their doctors receive higher reimbursements for routine office visits. In contrast, increased reimbursement rates for screening tests do not have a uniform effect on whether Medicaid beneficiaries get screened. [More]
Genetic testing, risk factor assessment could improve prevention strategies for breast cancer

Genetic testing, risk factor assessment could improve prevention strategies for breast cancer

Scientists used mathematical models to show that analysing genetic data, alongside a range of other risk factors, could substantially improve the ability to flag up women at highest risk of developing breast cancer. [More]
Internet based screening mammography training: an interview with Dr. Holzhauer

Internet based screening mammography training: an interview with Dr. Holzhauer

About half of Radiologists in the USA who participate in breast imaging are estimated to read less than 2,000 screening mammograms per year. This is a suboptimal number, given that only 3-5 cancers in average are seen among 1,000 screening mammograms. [More]
Primary care providers recommend LDCT screening for high-risk lung cancer patients

Primary care providers recommend LDCT screening for high-risk lung cancer patients

Patients at high-risk for developing lung cancer are more likely to receive low-dose computed tomography (LDCT) screening when their primary care provider is familiar with guideline recommendations for LDCT screening for lung cancer, according to research presented today at the 2014 Chicago Multidisciplinary Symposium in Thoracic Oncology. [More]
Coordinated Health launches #Ch435pledge campaign to provide free mammography exams

Coordinated Health launches #Ch435pledge campaign to provide free mammography exams

Each year in Lehigh Valley, an estimated 435 women will be diagnosed with breast cancer and one in eight will be diagnosed with breast cancer in her lifetime, data extrapolated from reports by the National Cancer Institute's SEER program and the Lehigh Valley Planning Commission. [More]

PANDORA Jewelry, NBCF partner to fight against breast cancer

In support of the fight against breast cancer, PANDORA Jewelry announced a partnership with the National Breast Cancer Foundation, Inc. As part of the new partnership, the sale of existing pink ribbon charms will directly benefit the organization. This marks the first year of their partnership. [More]
Molecular breast imaging: an interview with Jim Calandra, CEO Gamma Medica

Molecular breast imaging: an interview with Jim Calandra, CEO Gamma Medica

Studies have shown that mammograms fail to detect cancers in one-third to one-half of women with dense breasts (Clinical Literature on MBI). In some cases, the findings from a mammogram are inconclusive and secondary screening will almost always be required. [More]
Women can now take proactive steps to reduce breast cancer risk

Women can now take proactive steps to reduce breast cancer risk

Now that medical professionals have identified gene mutations that predispose for breast cancer, patients can take proactive steps to reduce their risk. [More]

Pure Madness Chocolate to donate portion of sales to National Breast Cancer Foundation

Pure Madness Chocolate will donate a portion of sales from their Luscious Truffle Collection during the month of October to the National Breast Cancer Foundation, Inc.® (NBCF). [More]
Photoacoustics could become alternative to mammography or sonogram for breast cancer detection

Photoacoustics could become alternative to mammography or sonogram for breast cancer detection

One of the lines of research of OILTEBIA, a European science project coordinated by Universidad Carlos III de Madrid, is a method to detect breast cancer based on photoacoustics and which could become an alternative to mammography or sonogram. [More]